Studies on the promoter region of the c-Ha-ras oncogene.
Rapoport
B
B
Department of Medicine, Veterans' Administration Medical Center, San Francisco, California.
Damante
G
G
Dere
W
W
Filetti
S
S
D000818:Animals; D001483:Base Sequence; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D000242:Cyclic AMP / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D007438:Introns; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D011519:Proto-Oncogenes; D012315:RNA Caps / Q000235:genetics; D051381:Rats; D012689:Sequence Homology, Nucleic Acid; D013268:Stimulation, Chemical; D013961:Thyroid Gland / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D013972:Thyrotropin / Q000494:pharmacology
D011518:Proto-Oncogene Proteins; D012315:RNA Caps; D013972:Thyrotropin; D000242:Cyclic AMP; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)